Constantly condensing the truth
The Scientific Advisory Board will assist the company in evaluating its product development and make recommendations to the company
Development strategy/pipeline deployment/production process to give professional evaluation/advice/decision.
In May 2024, he joined Shanghai Lishan Biomedicine Co., LTD
Master of Hospital Administration and Doctor of Public Health, University of Alabama Birmingham, USA, licensed physician in the United States, and certified clinical pathology specialist in the United States. Dr. Li Changqing has extensive experience in phase I-IV global clinical trials in the fields of oncology, immunotherapy, anti-inflammatory, gastrointestinal and gynecological diseases. He has led hundreds of clinical trials and more than 30 new drug filings worldwide.
Shanghai Public Network Anbei 31011502402974